Deep Vakil

Dr. Deep Vakil

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
NBNiharika Bhatia
Niharika Bhatia
DVDeep Vakil
Deep Vakil
SZStavros Zinonos
Stavros Zinonos
JCJavier Cabrera
Javier Cabrera
NCNora M. Cosgrove
Nora M. Cosgrove
DSDavit Sargsyan
Davit Sargsyan
Background: In 1998, President Clinton launched a federal initiative to eliminate racial and ethnic health disparities. The impact on the outcomes of ST‐segment–elevation myocardial infarction has not been well studied. Methods and Results: ST‐segment–elevation myocardial infarction outcomes from 1994 to 2015 were studied in 7942 Black, 27 665 Hispanic, and 88 727 White patients with first admission of ST‐segment–elevation myocardial infarction using the Myocardial Infarction Data Acquisition System. Logistic regressions were used to assess mortality adjusting for demographics, comorbidities, and interventional procedures. There was an overall rise from 1994 to 2015 in the use of percutaneous coronary interventions in all 3 groups. Before 1998, White patients received more percutaneous coronary interventions compared with Black and Hispanic patients ( P <0.05). After 1998, the disparity in use of percutaneous coronary interventions in Black and Hispanic patients was greatly reduced compared with White patients, and the difference reversed in favor of Hispanic patients after 2005 ( P <0.05). There was an overall downward trend of in‐hospital mortality without evidence of disparity among Black, Hispanic, and White patients. A linear regression model was used with a change point in 1998. Before 1998, the slope of 1‐year all‐cause and cardiovascular mortality was not statistically significant. After 1998, the mortality showed negative slopes for all 3 groups, however, with lower overall crude mortality for Hispanic patients compared with Black and White patients ( P <0.0001). Conclusions: The initiative launched in 1998 may have contributed to a reduction in percutaneous coronary intervention usage disparity in patients with ST‐segment–elevation myocardial infarction. Short‐ and long‐term mortality decreased in all 3 groups, but more in the Hispanic population.

2 June 2021 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
PDF file
DVDeep Vakil
Deep Vakil
SZStavros Zinonos
Stavros Zinonos
JKJohn B. Kostis
John B. Kostis
JDJeanne M. Dobrzynski
Jeanne M. Dobrzynski
NCNora M. Cosgrove
Nora M. Cosgrove
WKWilliam J. Kostis
William J. Kostis
This post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) examined the performance of chlorthalidone (C) versus amlodipine (A) monotherapies. ANOVA was used to analyze the differences in systolic blood pressure (SBP) response between C and A. Logistic regression was used to examine monotherapy failure (adding a second antihypertensive agent or switching to a different antihypertensive agent) rates. Four hundred ninety‐one participants were treated with C monotherapy (n = 210, mean dose = 22 mg/day) or A monotherapy (n = 281, mean dose = 7 mg/day). There was a significant difference in mean SBP reduction between the C and A monotherapies at the third visit (higher reduction with A, adjusted p = .018). Unadjusted analysis showed a higher failure with C in the standard treatment group. Although the average SBP at failure was higher and above the 140 mm Hg cutoff that indicated monotherapy failure with A (142.60) compared with C (138.40), more participants on C failed despite having SBP below the 140 cutoff. This was probably due to decisions made by the investigative teams to change the antihypertensive regimen, because, in their opinion, the clinical picture required it. After adjusting for baseline characteristics, C had higher failure than A only in the standard treatment group (1.64 odds ratio [OR], 95% CI 1.06–2.56, p = .028). A sub‐analysis including participants who had never used antihypertensive treatment before randomization had similar results (2.57 OR, 95% CI 1.34–5.02, p = .004). Overall, in SPRINT chlorthalidone was associated with higher monotherapy failure than amlodipine in the standard treatment group because of decisions of the investigative teams.

20 May 2024 in The American Surgeon™
Verified
Journal Article
Closed access
MMMonique Motta
Monique Motta
AAAzalia Avila
Azalia Avila
HCHayley M. Carroll
Hayley M. Carroll
DVDeep Vakil
Deep Vakil
JHJennifer Hernandez
Jennifer Hernandez
JPJoshua P. Parreco
Joshua P. Parreco
Background: In the setting of limited funding and high expectations for quality care, safety net hospitals play a crucial role in treating pediatric trauma patients. This study aimed to compare outcomes and hospitalization costs of pediatric trauma patients in safety net hospitals across the United States. Methods: The Nationwide Readmissions Database for 2016-2020 was queried for all patients under the age of 18 years hospitalized for traumatic injury. Patients admitted to safety net hospitals were propensity matched 1:1 to all other patients. The primary outcome was mortality. The secondary outcomes were readmission within 1-year, mean length of stay (LOS), total charges, and total hospitalization costs including readmissions. Results: There were 176,325 patients meeting inclusion criteria, and 30,869 were admitted to safety net hospitals. All safety net patients were successfully matched across predictors, and 61,738 patients were included. The overall mortality rate was 1.4% (n = 834), and the mortality risk was similar in safety net hospitals (OR 1.11 [.96-1.27] P = .15). The overall readmission rate, mean LOS, and mean total cost were similar for safety net hospitals when compared to all hospitals. However, the overall mean total charge was $78,724 (±$224,884) and was lower in safety net hospitals ($76,575 [±$198,342], P = .02). Discussion: Safety net hospitals deliver comparable outcomes as other health care facilities when caring for pediatric trauma patients. Notably, these hospitals appear to undercharge for their services, despite incurring similar costs in the process. These results shed light on the resilience of safety net hospitals in delivering quality and cost-effective care.

20 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Kumar JayantKumar Jayant
Kumar Jayant
JMJonathan Magloire
Jonathan Magloire
LQLuis Quintero
Luis Quintero
DVDeep Vakil
Deep Vakil
HBHimani Bhatt
Himani Bhatt
HNHolly Neville
Holly Neville
Background: Bone hemangiomas are rare benign vascular tumors, comprising less than 1% of all bone tumors. They are predominantly found in the vertebral body or skull; rib hemangiomas are particularly rare and are often misdiagnosed as malignant tumors. Given the high malignancy rate of primary rib tumors, understanding rib hemangiomas is crucial to avoid misdiagnosis. Methods: A systematic review was conducted according to PRISMA standards. A comprehensive literature search was performed in PubMed, EMBASE, Web of Science, and Scopus. Data on patient demographics, tumor characteristics, and clinical presentation were analyzed using STATA/SE 17. Results: From 306 articles, 40 studies including 43 patients met the inclusion criteria. Rib hemangiomas showed a bimodal age distribution, with peaks in patients younger than 30 years (mean age 21.43 ± 5.60 years) and ≥30 years (mean age 59.96 ± 9.70 years). Females were more affected (62.79%) than males (37.21%), with a ratio of 1.69:1. The tumors were most frequently located in mid-thoracic ribs (4–8) and predominantly on the left side of the thorax. The mean tumor size was 7.27 cm, with 76.19% exhibiting osteolytic changes. Clinically, 63.41% of cases were asymptomatic, while symptomatic cases mainly presented with pain. Conclusions: Rib hemangiomas, though rare, should be considered in the differential diagnosis of thoracic tumors. They present as well-demarcated lytic lesions with distinct imaging features, and they typically require complete surgical excision, which may be aided with preoperative embolization. Their accurate diagnosis involves a combination of radiologic and clinical evaluation. Further studies are needed to understand the disease’s pathophysiology and to refine diagnostic and treatment protocols.

17 June 2025 in The American Surgeon™
Verified
Journal Article
Closed access
HBHimani Bhatt
Himani Bhatt
DVDeep Vakil
Deep Vakil
LQLuis Quintero
Luis Quintero
MMMonique Motta
Monique Motta
MVMaria Vashchenko
Maria Vashchenko
OLOmar H. Llaguna
Omar H. Llaguna
Introduction: Peritoneal mesothelioma (PM) is a rare cancer associated with high mortality. No studies exist using the National Cancer Database (NCDB) that have examined factors associated with long-term survival (LTS). Methods: NCDB 2006-2019 was queried for patients with PM. Primary objective was to determine the characteristics of LTS among patients with peritoneal mesothelioma. Secondary objective: identified predictors of LTS were then used to develop and internally validate a nomogram to predict the probability of LTS among patients. LTS was defined as 5 or more years of survival after diagnosis. Univariate and multivariate logistic analyses were performed. Results: The study included 3,636 patients with PM, 17.8% had LTS. The median survival time was 17.7 months. For LTS, the median survival time was ∼92 months while the median survival time of non-long-term survivors (NLTS) was 11.7 months. Following factors were common with LTS patients compared to the NLTS: female, younger, privately insured, treatment at academic/research institutions and treatment at high case volume institutions, Charlson-Deyo comorbidity score of 0, receiving radical surgery, receiving chemotherapy, greater proportion of grade 1 disease, negative lymph nodes, and lower rates of lymphovascular invasion ( P < .001). The nomogram included age, gender, and surgical margins. Conclusion: A subset of PM patients can be long-term survivors with effective patient selection and appropriate care. This study highlights critical factors that influence LTS, paving the way for personalized treatment strategies and enhanced prognostication. Further research is needed to improve patient selection and ensure patients likely to be LTS receive adequate care.

17 April 2024 in The American Surgeon™
Verified
Journal Article
Closed access
DVDeep Vakil
Deep Vakil
JPJennifer Palacio
Jennifer Palacio
MMMonique Motta
Monique Motta
ZSZaineb N. Shatawi
Zaineb N. Shatawi
JCJuliana L. Colvin
Juliana L. Colvin
OLOmar H. Llaguna
Omar H. Llaguna
Gastropleural fistulas are rare complications with significant mortality and morbidity. There are limited reports on the successful management of gastropleural fistulas with advanced endoscopic procedures. The following case of a 75-year-old woman with a history of recurrent pseudomyxoma peritonei secondary to ruptured low-grade appendiceal mucinous neoplasm status post cytoreductive surgery highlights the successful treatment of a gastropleural fistula with endoscopic suturing.